Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 190

1.

Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco.

Hahn JA, Page-Shafer K, Lum PJ, Ochoa K, Moss AR.

Hepatology. 2001 Jul;34(1):180-7.

PMID:
11431749
2.

Trends in sources and sharing of needles among people who inject drugs, San Francisco, 2005-2012.

Kim NJ, Jin H, McFarland W, Raymond HF.

Int J Drug Policy. 2015 Dec;26(12):1238-43. doi: 10.1016/j.drugpo.2015.08.013. Epub 2015 Aug 22.

PMID:
26365768
3.

Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study).

Evans JL, Hahn JA, Page-Shafer K, Lum PJ, Stein ES, Davidson PJ, Moss AR.

J Urban Health. 2003 Mar;80(1):137-46.

4.

Hepatitis C virus risk behaviors within the partnerships of young injecting drug users.

Hahn JA, Evans JL, Davidson PJ, Lum PJ, Page K.

Addiction. 2010 Jul;105(7):1254-64. doi: 10.1111/j.1360-0443.2010.02949.x. Epub 2010 May 14.

5.

HCV infection prevalence lower than expected among 18-40-year-old injection drug users in San Diego, CA.

Garfein RS, Rondinelli A, Barnes RF, Cuevas J, Metzner M, Velasquez M, Rodriguez D, Reilly M, Xing J, Teshale EH.

J Urban Health. 2013 Jun;90(3):516-28. doi: 10.1007/s11524-012-9728-0.

6.

Prevalence and incidence of hepatitis C virus infection among young adult injection drug users.

Garfein RS, Doherty MC, Monterroso ER, Thomas DL, Nelson KE, Vlahov D.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S11-9.

PMID:
9663618
7.

Hepatitis C virus seroconversion among young injection drug users: relationships and risks.

Hahn JA, Page-Shafer K, Lum PJ, Bourgois P, Stein E, Evans JL, Busch MP, Tobler LH, Phelps B, Moss AR.

J Infect Dis. 2002 Dec 1;186(11):1558-64. Epub 2002 Nov 4.

PMID:
12447730
8.

Concordance of risk behavior reporting within HCV serodiscordant injecting partnerships of young injection drug users in San Francisco, CA.

Evans JL, Morris MD, Yu M, Page K, Hahn JA.

Drug Alcohol Depend. 2014 Sep 1;142:239-44. doi: 10.1016/j.drugalcdep.2014.06.028. Epub 2014 Jul 4.

9.

[Sharing of needles and paraphernalia injection in new and long-term injection drug users in Sichuan, China].

Liu JB, Zhang LL, Lai WH, Feng L, Zeng YL, Liu L, Hu Y, Li J, Zhang XL, Xiao Y, Vermund SH, Jia YJ.

Zhonghua Liu Xing Bing Xue Za Zhi. 2009 Jul;30(7):656-62. Chinese.

PMID:
19957584
10.

High hepatitis C virus prevalence and incidence in a community cohort of young heroin injectors in a context of extensive harm reduction programmes.

Vallejo F, Barrio G, Brugal MT, Pulido J, Toro C, Sordo L, Espelt A, Bravo MJ; Itinere Project Group.

J Epidemiol Community Health. 2015 Jun;69(6):599-603. doi: 10.1136/jech-2014-205070. Epub 2015 Apr 13.

PMID:
25870164
11.

Alarming epidemics of human immunodeficiency virus and hepatitis C virus among injection drug users in the northwestern bordering state of Punjab, India: prevalence and correlates.

Panda S, Roy T, Pahari S, Mehraa J, Sharma N, Singh G, Singh J, Joseph F, Singh S, Sharma NM.

Int J STD AIDS. 2014 Jul;25(8):596-606. doi: 10.1177/0956462413515659. Epub 2013 Dec 18.

PMID:
24352120
12.

Low incidence and prevalence of hepatitis C virus infection among sexually active non-intravenous drug-using adults, San Francisco, 1997-2000.

Hammer GP, Kellogg TA, McFarland WC, Wong E, Louie B, Williams I, Dilley J, Page-Shafer K, Klausner JD.

Sex Transm Dis. 2003 Dec;30(12):919-24.

PMID:
14646642
13.
14.

Intimate injection partnerships are at elevated risk of high-risk injecting: a multi-level longitudinal study of HCV-serodiscordant injection partnerships in San Francisco, CA.

Morris MD, Evans J, Montgomery M, Yu M, Briceno A, Page K, Hahn JA.

PLoS One. 2014 Oct 6;9(10):e109282. doi: 10.1371/journal.pone.0109282. eCollection 2014.

15.

Risk factors for hepatitis C virus infection among street youths.

Roy E, Haley N, Leclerc P, Boivin JF, C├ędras L, Vincelette J.

CMAJ. 2001 Sep 4;165(5):557-60.

16.

The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence.

Turner KM, Hutchinson S, Vickerman P, Hope V, Craine N, Palmateer N, May M, Taylor A, De Angelis D, Cameron S, Parry J, Lyons M, Goldberg D, Allen E, Hickman M.

Addiction. 2011 Nov;106(11):1978-88. doi: 10.1111/j.1360-0443.2011.03515.x. Epub 2011 Aug 24.

PMID:
21615585
17.

Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.

Neaigus A, Zhao M, Gyarmathy VA, Cisek L, Friedman SR, Baxter RC.

J Urban Health. 2008 May;85(3):309-22. doi: 10.1007/s11524-008-9271-1. Epub 2008 Mar 14.

18.

Socio-behavioral and geographic correlates of prevalent hepatitis C virus infection among young injection drug users in metropolitan Baltimore and Chicago.

Boodram B, Golub ET, Ouellet LJ.

Drug Alcohol Depend. 2010 Sep 1;111(1-2):136-45. doi: 10.1016/j.drugalcdep.2010.04.003. Epub 2010 May 15.

PMID:
20472373
19.

Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection.

Patrick DM, Tyndall MW, Cornelisse PG, Li K, Sherlock CH, Rekart ML, Strathdee SA, Currie SL, Schechter MT, O'Shaughnessy MV.

CMAJ. 2001 Oct 2;165(7):889-95.

20.

Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.

Vicknasingam B, Narayanan S, Navaratnam V.

Drug Alcohol Rev. 2009 Jul;28(4):447-54. doi: 10.1111/j.1465-3362.2009.00087.x.

PMID:
19594801

Supplemental Content

Support Center